AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...
Guidelines emphasize single-pill combinations and deprescribing strategies to combat polypharmacy and hyperpolypharmacy in ...
LAS VEGAS—The American Heart Association is launching an AI Assessment Lab in partnership with Dandelion Health to validate predictive AI for cardiovascular conditions and related diseases. The group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results